Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Oxigene begins phase II trial of CA4P in thyroid cancer

Jan. 3, 2003

Discovery of Src kinase inhibitors reported by AstraZeneca

Jan. 2, 2003

New caspase activators and their use in cancer and autoimmune diseases

Jan. 2, 2003

Gleevec granted FDA approval for first-line treatment of CML

Jan. 2, 2003

Casodex 150 mg not recommended for use in U.S. in early prostate cancer

Jan. 2, 2003

Onconase receives fast track designation for malignant mesothelioma

Jan. 2, 2003

PSMA Development prostate cancer vaccine enters phase I

Jan. 2, 2003

GlycoGenesys acquires Elan's interest in joint venture

Jan. 2, 2003

Novel paclitaxel formulation ABI-007 evaluated in cancer patients

Jan. 2, 2003

Antitumor activity reported for CCI-779 in advanced/metastatic breast cancer

Jan. 2, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026